ImmuCell Corporation ICCC
NASDAQ · United States · Health Technology
$9.75+0.15 (+1.56%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | 2022-02-22 | -0.01 | -0.01 | 0.0% | $5.40M | 0.0% |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.